证券时报·2025-09-15 09:49Market Overview - A-shares showed mixed performance today, with the Shanghai Composite Index declining by 0.26% to 3860.5 points, while the Shenzhen Component Index rose by 0.63% to 13005.77 points, and the ChiNext Index increased by 1.52% to 3066.18 points [1] - The total trading volume in the Shanghai and Shenzhen markets was 23034 billion, a decrease of 2452 billion from the previous day [1] Automotive Sector - The automotive industry chain stocks experienced a strong rally, with companies like Haoen Automotive and Wanxiang Qianchao hitting the daily limit, and Zhejiang Shibao also reaching the limit [4][5] - The Ministry of Industry and Information Technology, along with seven other departments, released a plan to promote the industrial application of intelligent connected vehicles, which is expected to reshape competition in the automotive industry towards value-based competition [6] Semiconductor Sector - The semiconductor sector was active, with stocks like Shengbang Co. and Shanghai Beiling hitting the daily limit, and Naxinwei rising over 10% [10][11] - Recent U.S. trade measures have led to increased domestic substitution intentions among customers, which may benefit local semiconductor manufacturers [13] Energy Storage Sector - The National Development and Reform Commission and the National Energy Administration announced a plan for new energy storage, aiming for over 100 million kilowatts of new installed capacity by 2027, which could drive direct investment of about 250 billion [8] - The storage battery supply chain is experiencing strong demand, with a 106% year-on-year increase in global storage battery shipments in the first half of the year [9] Biotechnology Sector - The stock of Yaojie Ankang surged over 110% in a single day, with a cumulative increase of nearly 500% over the past four trading days [15][16] - The company focuses on innovative therapies for cancer and metabolic diseases and recently received clinical approval for its core product, Tinengotinib, for treating specific breast cancer patients [17]